4//SEC Filing
Macdonald Alistair 4
Accession 0001209191-21-037755
CIK 0001610950other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:08 PM ET
Size
11.9 KB
Accession
0001209191-21-037755
Insider Transaction Report
Form 4
Macdonald Alistair
Chief Operating Officer
Transactions
- Sale
Class A Common Stock
2021-06-01$88.20/sh−4,889$431,210→ 200,470 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2021-06-01−4,889→ 0 totalExercise: $42.88Exp: 2026-01-19→ Class A Common Stock (4,889 underlying) - Exercise/Conversion
Class A Common Stock
2021-06-01$42.88/sh+4,889$209,640→ 205,359 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2020.
- [F2]The shares subject to this option vested in four approximately equal annual installments on January 19, 2017; January 19, 2018; January 19, 2019; and January 19, 2020.
Issuer
Syneos Health, Inc.
CIK 0001610950
Entity typeother
Related Parties
1- filerCIK 0001624073
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:08 PM ET
- Size
- 11.9 KB